Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study

Daniel R. Gomez(The University of Texas MD Anderson Cancer Center), George R. Blumenschein(The University of Texas MD Anderson Cancer Center), J Jack Lee(The University of Texas MD Anderson Cancer Center), Mike Hernández(The University of Texas MD Anderson Cancer Center), Rong Ye(The University of Texas MD Anderson Cancer Center), D. Ross Camidge(University of Colorado Denver), Robert C. Doebele(University of Colorado Denver), Ferdinandos Skoulidis(The University of Texas MD Anderson Cancer Center), Laurie E. Gaspar(University of Colorado Denver), Don L. Gibbons(The University of Texas MD Anderson Cancer Center), José A. Karam(The University of Texas MD Anderson Cancer Center), Brian D. Kavanagh(University of Colorado Denver), Chad Tang(The University of Texas MD Anderson Cancer Center), Ritsuko Komaki(The University of Texas MD Anderson Cancer Center), Alexander V. Louie(London Health Sciences Centre), David A. Palma(London Health Sciences Centre), Anne S. Tsao(The University of Texas MD Anderson Cancer Center), Boris Sepesi(The University of Texas MD Anderson Cancer Center), William N. William(The University of Texas MD Anderson Cancer Center), Jianjun Zhang(The University of Texas MD Anderson Cancer Center), Qiuling Shi(The University of Texas MD Anderson Cancer Center), Xin Shelley Wang(The University of Texas MD Anderson Cancer Center), Stephen G. Swisher(The University of Texas MD Anderson Cancer Center), John V. Heymach(The University of Texas MD Anderson Cancer Center)
The Lancet Oncology
October 24, 2016
Cited by 1,078Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis